Ellen Reich: The View From a CAR T-Cell Clinical Trial
After exhausting her treatment options, Ellen Reich got CAR T-cell treatment for multiple myeloma through a clinical trial.
Home > Patients, Caregivers, and Advocates > Survivors > The View From a CAR T-Cell Clinical Trial
After exhausting her treatment options, Ellen Reich got CAR T-cell treatment for multiple myeloma through a clinical trial.
Learn about physician-scientists and cancer researchers like Fellow of the AACR Academy Lewis C. Cantley, PhD, who are driving progress against cancer.
Learn MoreThere are many ways in which you can lend your talents to support lifesaving research. Learn how you can become an advocate for cancer research, participate in events to raise awareness, volunteer your time, and share your story of how cancer has affected your life.
Get InvolvedFDA Approvals in Oncology: July-September 2024
Learn MoreReclaiming the Joys of Retirement, Thanks to CAR T-Cell Therapy
Learn MoreNew Perspectives on the Risk of Secondary Cancers After CAR T-cell Therapy
Learn More